Compare Immunovant Inc. Common Stock (IMVT) vs Centrus Energy Corp (LEU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Centrus Energy Corp — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Centrus Energy Corp trades at $144.8 (market cap $3.01B). The key difference: Immunovant Inc. Common Stock is far larger — about 2.2× Centrus Energy Corp's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Centrus Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Centrus Energy Corp for 29 Days on average.
| IMVT | LEU | |
|---|---|---|
Market Cap | $6.62B | $3.01B |
Volume | 1,131,364 | 868,801 |
Sector | Health | Energy |
52-Week High | $44.96 | $436.00 |
52-Week Low | $17.03 | $138.18 |
Typical Hold Time | 0 Days | 29 Days |
Enterprise Value | $5.72B | $2.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Centrus Energy (LEU) trades at $147.14, down 4.38% on the day, with a neutral technical signal. The company reported Q2 2026 EPS of $0.77, beating estimates, but faces declining profitability margins into 2026. Recent news highlights its strategic position as a supplier of High-Assay Low-Enriched Uranium (HALEU), benefiting from U.S. nuclear energy growth and partnerships, though execution risks remain high.
Outlook is mixed: strong analyst consensus price target of $218.10 implies significant upside, supported by nuclear sector tailwinds and new contracts. However, high valuation multiples (P/E 77.85), volatile cash flows, and margin compression pose risks. Investors should weigh growth potential against execution challenges in a capital-intensive industry.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →
